Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
97,693,461
-
Total 13F shares
-
1,097,738
-
Share change
-
+1,097,738
-
Total reported value
-
$19,563,000
-
Price per share
-
$17.82
-
Number of holders
-
15
-
Value change
-
+$19,563,012
-
Number of buys
-
15
Institutional Holders of Rani Therapeutics Holdings Inc - Common Stock (RANI) as of Q3 2021
As of 30 Sep 2021,
Rani Therapeutics Holdings Inc - Common Stock (RANI) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,097,738 shares.
The largest 10 holders included
Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, CAAS CAPITAL MANAGEMENT LP, GOLDMAN SACHS GROUP INC, Squarepoint Ops LLC, STIFEL FINANCIAL CORP, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.